Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VONOPRAZAN vs VORASIDENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VONOPRAZAN vs VORASIDENIB: Safety Overview

Metric VONOPRAZAN VORASIDENIB
Total FAERS Reports 2,019 264
Deaths Reported 73 6
Death Rate 3.6% 2.3%
Hospitalizations 342 57
Average Patient Age 63.6 yrs 43.6 yrs
% Female Patients 65.3% 11.1%
FDA Approval Date Nov 1, 2023 Aug 6, 2024
Manufacturer Phathom Pharmaceuticals Inc. Servier Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription